Business

Drugmaker's Failed Trial Hits Market

Updated 2026-07-09 10:10 UTC 1 source Negative

Two pharmaceutical companies lost $27 billion in market value after their heart disease drug failed a Phase III trial, marking a significant setback for the industry.

Coverage timeline — 1 article

MarketWatch

Major drugmaker loses $27 billion in market value after failed trial

Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.

2026-07-09 09:53 UTC